Abrams Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,656,462
| Closed | -$14.2M | – | 18 |
|
|
2020
Q3 | $14.2M | Hold |
5,656,462
| – | – | 0.45% | 18 |
|
|
2020
Q2 | $76.8M | Hold |
5,656,462
| – | – | 2.48% | 15 |
|
|
2020
Q1 | $42.9M | Hold |
5,656,462
| – | – | 1.69% | 16 |
|
|
2019
Q4 | $35.7M | Hold |
5,656,462
| – | – | 1.11% | 19 |
|
|
2019
Q3 | $22.2M | Hold |
5,656,462
| – | – | 0.62% | 19 |
|
|
2019
Q2 | $27.4M | Hold |
5,656,462
| – | – | 0.74% | 18 |
|
|
2019
Q1 | $46.3M | Hold |
5,656,462
| – | – | 1.3% | 16 |
|
|
2018
Q4 | $31.3M | Buy |
5,656,462
+4,537,176
| +405% | +$25.1M | 1.29% | 15 |
|
|
2018
Q3 | $9.88M | Buy |
+1,119,286
| New | +$9.88M | 0.26% | 22 |
|